These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38798867)

  • 21. Circulating microRNA as a Novel Biomarker for Pulmonary Arterial Hypertension Due to Congenital Heart Disease.
    Chen W; Li S
    Pediatr Cardiol; 2017 Jan; 38(1):86-94. PubMed ID: 27837306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A diagnostic miRNA signature for pulmonary arterial hypertension using a consensus machine learning approach.
    Errington N; Iremonger J; Pickworth JA; Kariotis S; Rhodes CJ; Rothman AM; Condliffe R; Elliot CA; Kiely DG; Howard LS; Wharton J; Thompson AAR; Morrell NW; Wilkins MR; Wang D; Lawrie A
    EBioMedicine; 2021 Jul; 69():103444. PubMed ID: 34186489
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hemodynamic Evaluation of Children with Persistent or Recurrent Pulmonary Arterial Hypertension Following Complete Repair of Congenital Heart Disease.
    Latus H; Wagner I; Ostermayer S; Kerst G; Kreuder J; Schranz D; Apitz C
    Pediatr Cardiol; 2017 Oct; 38(7):1342-1349. PubMed ID: 28681131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pulmonary arterial hypertension in adults with congenital heart disease: markers of disease severity, management of advanced heart failure and transplantation.
    Jansen K; Constantine A; Condliffe R; Tulloh R; Clift P; Moledina S; Wort SJ; Dimopoulos K
    Expert Rev Cardiovasc Ther; 2021 Sep; 19(9):837-855. PubMed ID: 34511015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation between congenital heart disease complicated with pulmonary artery hypertension and circulating endothelial cells as well as endothelin-1.
    Li X; Qiu J; Pan M; Zheng D; Su Y; Wei M; Kong X; Sun W; Zhu J
    Int J Clin Exp Pathol; 2015; 8(9):10743-51. PubMed ID: 26617785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changing demographics of pulmonary arterial hypertension in congenital heart disease.
    Mulder BJ
    Eur Respir Rev; 2010 Dec; 19(118):308-13. PubMed ID: 21119189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Galectin-3 aggravates pulmonary arterial hypertension via immunomodulation in congenital heart disease.
    Shen Q; Chen W; Liu J; Liang Q
    Life Sci; 2019 Sep; 232():116546. PubMed ID: 31176777
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Research progress on the role of p53 in pulmonary arterial hypertension.
    Liu X; Liu B; Luo X; Liu Z; Tan X; Zhu K; Ouyang F
    Respir Investig; 2024 Jul; 62(4):541-550. PubMed ID: 38643536
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DAN plays important compensatory roles in systemic-to-pulmonary shunt associated pulmonary arterial hypertension.
    Meng L; Liu X; Teng X; Yuan W; Duan L; Meng J; Li J; Zheng Z; Wei Y; Hu S
    Acta Physiol (Oxf); 2019 Jul; 226(3):e13263. PubMed ID: 30715799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation and Management of Pulmonary Arterial Hypertension in Congenital Heart Disease.
    Arshad HB; Duarte VE
    Methodist Debakey Cardiovasc J; 2021; 17(2):145-151. PubMed ID: 34326934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human lung microRNA profiling in pulmonary arterial hypertension secondary to congenital heart defect.
    Ma K; Zhao Q; Chen W; Zhang H; Li S; Pan X; Chen Q
    Pediatr Pulmonol; 2015 Dec; 50(12):1214-23. PubMed ID: 25847058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selexipag treatment for pulmonary arterial hypertension associated with congenital heart disease after defect correction: insights from the randomised controlled GRIPHON study.
    Beghetti M; Channick RN; Chin KM; Di Scala L; Gaine S; Ghofrani HA; Hoeper MM; Lang IM; McLaughlin VV; Preiss R; Rubin LJ; Simonneau G; Sitbon O; Tapson VF; Galiè N
    Eur J Heart Fail; 2019 Mar; 21(3):352-359. PubMed ID: 30632656
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pulmonary arterial hypertension in adults with congenital heart disease: distinct differences from other causes of pulmonary arterial hypertension and management implications.
    Dimopoulos K; Giannakoulas G; Wort SJ; Gatzoulis MA
    Curr Opin Cardiol; 2008 Nov; 23(6):545-54. PubMed ID: 18830068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pulmonary arterial hypertension: closing the gap in congenital heart disease.
    Brida M; Nashat H; Gatzoulis MA
    Curr Opin Pulm Med; 2020 Sep; 26(5):422-428. PubMed ID: 32657834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dynamic Changes in miR-21 Regulate Right Ventricular Dysfunction in Congenital Heart Disease-Related Pulmonary Arterial Hypertension.
    Chang WT; Wu CC; Lin YW; Shih JY; Chen ZC; Wu SN; Wu CC; Hsu CH
    Cells; 2022 Feb; 11(3):. PubMed ID: 35159373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CYLD mediates human pulmonary artery smooth muscle cell dysfunction in congenital heart disease-associated pulmonary arterial hypertension.
    Zhou JJ; Li H; Li L; Li Y; Wang PH; Meng XM; He JG
    J Cell Physiol; 2021 Sep; 236(9):6297-6311. PubMed ID: 33507567
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pulmonary arterial hypertension in adult congenital heart disease.
    Brida M; Gatzoulis MA
    Heart; 2018 Oct; 104(19):1568-1574. PubMed ID: 29720395
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma Connective Tissue Growth Factor as a Biomarker of Pulmonary Arterial Hypertension Associated With Congenital Heart Disease in Adults.
    Liu W; Hua Y; Zheng D; Lv W; Zhang W; Chen Q; Huang R; Li X
    Circ J; 2023 Mar; 87(4):527-535. PubMed ID: 36843115
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pulmonary Hypertension in Adults with Congenital Heart Disease.
    Goldstein SA; Krasuski RA
    Cardiol Clin; 2022 Feb; 40(1):55-67. PubMed ID: 34809917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synemin promotes pulmonary artery smooth muscle cell phenotypic switch in shunt-induced pulmonary arterial hypertension.
    Zhou J
    ESC Heart Fail; 2022 Oct; 9(5):3221-3231. PubMed ID: 35769011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.